Showing results (471-480 of 659) with videos related to
Sort By:
Pageof 66
Frontiers in Immunology|July 18, 2019
CRTAM Protects Against Intestinal Dysbiosis During Pathogenic Parasitic Infection by Enabling Th17 MaturationLuisa Cervantes-Barragan, Victor S Cortez, Qiuling Wang, et al.Brain, Behavior, and Immunity|April 25, 2021
Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in miceSusanne Stutte, Janina Ruf, Ina Kugler, et al.Immunity|June 3, 2018
The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid CellsJennifer K Bando, Susan Gilfillan, Christina Song, et al.Nature Communications|April 17, 2021
TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activationEi'ichi Iizasa, Yasushi Chuma, Takayuki Uematsu, et al.Materials Horizons|January 18, 2022
Intrinsic carbon nanotube liquid crystalline elastomer photoactuators for high-definition biomechanicsJuzhong Zhang, Dandan Sun, Bin Zhang, et al.Journal of Materials Science. Materials in Medicine|August 19, 2018
Assessment of the degradation rates and effectiveness of different coated Mg-Zn-Ca alloy scaffolds for in vivo repair of critical-size bone defectsNan Zhang, Dewei Zhao, Na Liu, et al.Molecular Biology Reports|November 6, 2024
Differential proteomic profiles of exosomes in pediatric and adult adamantinomatous craniopharyngioma cyst fluidYiguang Chen, Ziyu Wang, Qin Huang, et al.BMC Cancer|February 21, 2022
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosisXiaowei Zhang, Yuchen Wu, Xuefei Sun, et al.Nature Aging|April 28, 2023
Alzheimer's disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosisRaz Dvir-Szternfeld, Giulia Castellani, Michal Arad, et al.Oncotarget|May 4, 2017
Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphomaXuefei Sun, Jing Liu, Yaming Wang, et al.Pageof 66